Bank Of New York Mellon Corp An2 Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$7.94 - $15.6 $251,570 - $494,270	31,684 New	31,684 $313 Million
Q4 2022 Feb 14, 2023	BUY	$8.51 - $19.69 $262,618 - $607,633	30,860 New	30,860 $294,000
Q3 2022 Nov 14, 2022	BUY	$7.61 - $22.29 $103,351 - $302,720	13,581 New	13,581 $236,000

13.8M

Ticker ANTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,402,700
Market Cap $21.9M
Description
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.